Discovery and Validation of 3 Novel DNA Methylation Markers of Prostate Cancer Prognosis-Reference-Cited by-同舟云学术

Discovery and Validation of 3 Novel DNA Methylation Markers of Prostate Cancer Prognosis

Published:2007-05 Issue:5 Volume:177 Page:1753-1758
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Cottrell Susan¹,Jung Klaus²,Kristiansen Glen²,Eltze Elke³,Semjonow Axel³,Ittmann Michael⁴,Hartmann Arndt⁵,Stamey Thomas⁶,Haefliger Carolina⁷,Weiss Gunter⁷

Affiliation:

1. Epigenomics, Inc., Seattle, Washington

2. University Hospital Charité, Berlin

3. Prostate Center, University of Muenster, Muenster

4. Baylor College of Medicine, Houston, Texas

5. Institute of Pathology, University of Regensburg, Regensburg, Germany

6. Stanford University Medical Center, Stanford, California

7. Epigenomics AG, Berlin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

2. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results;Roehl;J Urol,2004

3. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer;Messing;N Engl J Med,1999

4. Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program;See;J Urol,2002

5. Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years;Wirth;J Urol,2004

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Target repositioning using multi-layer networks and machine learning: The case of prostate cancer;Computational and Structural Biotechnology Journal;2024-12

2. ABHD5 as a friend or an enemy in cancer biology?;Frontiers in Oncology;2024-09-12

3. Identifying a Risk Signature of Methylation-Driven Genes as a Predictor of Survival Outcome for Colon Cancer Patients;Applied Biochemistry and Biotechnology;2023-10-31

4. Cohort profile: the Turin prostate cancer prognostication (TPCP) cohort;Frontiers in Oncology;2023-10-06

5. Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer;Scientific Reports;2023-09-16